131 related articles for article (PubMed ID: 9514187)
1. Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats.
Humphreys RA; Kane KA; Parratt JR
J Cardiovasc Pharmacol; 1998 Mar; 31(3):418-23. PubMed ID: 9514187
[TBL] [Abstract][Full Text] [Related]
2. Ischaemic preconditioning and mast cell histamine release: microdialysis of isolated rat hearts.
Davani S; Muret P; Royer B; Kantelip B; Frances C; Millart H; Kantelip JP
Pharmacol Res; 2002 May; 45(5):383-90. PubMed ID: 12123626
[TBL] [Abstract][Full Text] [Related]
3. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
Reilly FD; Dimlich RV
Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
[TBL] [Abstract][Full Text] [Related]
4. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection.
Parikh V; Singh M
Pharmacol Res; 1999 Aug; 40(2):129-37. PubMed ID: 10433871
[TBL] [Abstract][Full Text] [Related]
5. Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts.
Wang P; Downey JM; Cohen MV
Basic Res Cardiol; 1996; 91(6):458-67. PubMed ID: 8996631
[TBL] [Abstract][Full Text] [Related]
6. Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart.
Parikh V; Singh M
J Cardiovasc Pharmacol; 1997 Aug; 30(2):149-56. PubMed ID: 9269940
[TBL] [Abstract][Full Text] [Related]
7. Cardiac mast cell stabilization and cardioprotective effect of ischemic preconditioning in isolated rat heart.
Parikh V; Singh M
J Cardiovasc Pharmacol; 1998 May; 31(5):779-85. PubMed ID: 9593079
[TBL] [Abstract][Full Text] [Related]
8. Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischaemic preconditioning.
Parikh V; Singh M
Mol Cell Biochem; 1999 Sep; 199(1-2):1-6. PubMed ID: 10544945
[TBL] [Abstract][Full Text] [Related]
9. Elevated blood glucose after compound 48/80 treatment is not related to hepatic mast cell degranulation in rats.
Dimlich RV; Reilly FD
Proc Soc Exp Biol Med; 1986 Dec; 183(3):321-7. PubMed ID: 3797416
[TBL] [Abstract][Full Text] [Related]
10. Mast cell degranulation--a mechanism for the anti-arrhythmic effect of endothelin-1?
Walsh SK; Kane KA; Wainwright CL
Br J Pharmacol; 2009 Jul; 157(5):716-23. PubMed ID: 19422371
[TBL] [Abstract][Full Text] [Related]
11. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury.
Barr ML; Carey JN; Nishanian GP; Roberts RF; Sakamaki Y; Darbinian SH; Starnes VA
J Thorac Cardiovasc Surg; 1998 Mar; 115(3):631-6; discussion 636-7. PubMed ID: 9535451
[TBL] [Abstract][Full Text] [Related]
12. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
Johnson HG; Sheridan AQ
Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
[TBL] [Abstract][Full Text] [Related]
13. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
Sun W; Wainwright CL
Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
[TBL] [Abstract][Full Text] [Related]
14. Mast cell degranulation and glucose homeostasis.
Nutr Rev; 1987 May; 45(5):152-3. PubMed ID: 3601255
[No Abstract] [Full Text] [Related]
15. Inhibition of oxidative enzymes by anti-allergy drugs.
White GJ
Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
[TBL] [Abstract][Full Text] [Related]
16. Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine.
Parenteau GL; Clark RE
Ann Thorac Surg; 1991 Oct; 52(4):832-8. PubMed ID: 1929638
[TBL] [Abstract][Full Text] [Related]
17. The antiarrhythmic effect of ischaemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanism.
Piacentini L; Wainwright CL; Parratt JR
Cardiovasc Res; 1993 Apr; 27(4):674-80. PubMed ID: 8324804
[TBL] [Abstract][Full Text] [Related]
18. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
Reilly FD; Cilento EV; McCuskey RS
Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
[TBL] [Abstract][Full Text] [Related]
19. Possible role of cardiac mast cells in norepinephrine-induced myocardial preconditioning.
Parikh V; Singh M
Methods Find Exp Clin Pharmacol; 1999 May; 21(4):269-74. PubMed ID: 10399134
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation.
Xiong W; Zhou R; Qu Y; Yang Y; Wang Z; Song N; Liang R; Qian J
Biomed Pharmacother; 2021 Sep; 141():111853. PubMed ID: 34237593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
